Obg-like ATPase 1 Genetic Deletion Leads to Dilated Cardiomyopathy in Mice and Structural Changes in Drosophila Heart
Related Experiment Video
Updated: Jun 24, 2026
Fluorescent Labeling of Drosophila Heart Structures
Published on: October 13, 2009
Insights
The Obg-like ATPase 1 (Ola1) gene is essential for maintaining heart health. Loss of Ola1 function in mice causes dilated cardiomyopathy and heart dysfunction, suggesting it as a potential therapeutic target.
Area of Science:
- Cardiology
- Molecular Biology
- Genetics
Background:
- Cardiomyopathy, a disease of the heart muscle, significantly contributes to heart failure.
- Its pathogenesis is multifactorial, involving genetic, environmental, and lifestyle factors.
- Identifying novel genes involved in cardiac pathophysiology is crucial for understanding and treating cardiomyopathy.
Purpose of the Study:
- To investigate the role of the novel gene Obg-like ATPase 1 (Ola1) in cardiac pathophysiology.
- To determine if loss of function for Ola1 leads to dilated cardiomyopathy.
- To evaluate Ola1's role using cardiac-specific knockout mouse and Drosophila models.
Main Methods:
- Generated cardiac-specific Ola1 knockout mice (OLA1-cKO).
- Utilized a Drosophila model with RNAi-mediated knock-down of Ola1 in heart cells.
- Assessed cardiac structure, function, and organismal development in both models.
Main Results:
- Cardiac-specific Ola1 deficiency in mice resulted in dilated cardiomyopathy (DCM) and left ventricular (LV) dysfunction.
- OLA1-cKO mice exhibited severe LV dilatation, thinned LV walls, reduced function, and in some cases, ventricular rupture and death.
- Drosophila studies showed abnormal heart structure, impaired heart function, growth reduction, and pupal lethality upon Ola1 knock-down.
Conclusions:
- Ola1 is critical for cardiac homeostasis.
- Deficiency in Ola1 leads to dilated cardiomyopathy and cardiac dysfunction.
- The Ola1 gene represents a potential therapeutic target for dilated cardiomyopathy and heart failure.
Abstract:
Cardiomyopathy, disease of the heart muscle, is a significant contributor to heart failure. The pathogenesis of cardiomyopathy is multifactorial and involves genetic, environmental, and lifestyle factors. Identifying and characterizing novel genes that contribute to cardiac pathophysiology are crucial for understanding cardiomyopathy and effective therapies. In this study, we investigated the role of a novel gene, Obg-like ATPase 1 ( Ola1 ), in cardiac pathophysiology using a cardiac-specific knockout mouse model as well as a Drosophila model. Our previous work demonstrated that OLA1 modulates the hypertrophic response of cardiomyocytes through the GSK-beta/beta-catenin signaling pathway. Furthermore, recent studies have suggested that OLA1 plays a critical role in organismal growth and development. For example, Ola1 null mice exhibit increased heart size and growth retardation. It is not known, however, if loss of function for Ola1 leads to dilated cardiomyopathy. We generated cardiac-specific Ola1 knockout mice (OLA1-cKO) to evaluate the role of OLA1 in cardiac pathophysiology. We found that Ola1 -cKO in mice leads to dilated cardiomyopathy (DCM) and left ventricular (LV) dysfunction. These mice developed severe LV dilatation, thinning of the LV wall, reduced LV function, and, in some cases, ventricular wall rupture and death. In Drosophila, RNAi-mediated knock-down specifically in developing heart cells led to the change in the structure of pericardial cells from round to elongated, and abnormal heart function. This also caused significant growth reduction and pupal lethality. Thus, our findings suggest that OLA1 is critical for cardiac homeostasis and that its deficiency leads to dilated cardiomyopathy and dysfunction. Furthermore, our study highlights the potential of the Ola1 gene as a therapeutic target for dilated cardiomyopathy and heart failure.
